Infinity Pharmaceuticals Overview

Infinity Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for INFI.

Quarterly SG&A Expenses

$3.75M

↑ 7.41% YoY

As of Jun 30, 2023

Annual SG&A Expenses (TTM)

$15.99M

↑ 11.97% YoY

Trailing 12 months ending Jun 30, 2023

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin